Moderate to severe psoriasis treatment challenges through the era of biological drugs
Abstract: Biological therapy has revolutionized moderate to severe psoriasis treatment. However, despite being more effective than conventional systemic treatments, some patients do not respond or lose response to biotechnological treatments or develop drug-antibodies, interfering with its safety an...
Main Authors: | Júlia Vide, Sofia Magina |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Dermatologia
2017-10-01
|
Series: | Anais Brasileiros de Dermatologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000500668&tlng=en |
Similar Items
-
The Impact of Smoking on Psoriasis Patients with Biological Therapies in a Bucharest Hospital
by: Maria-Magdalena Constantin, et al.
Published: (2021-07-01) -
Old and New Biological Therapies for Psoriasis
by: Kirsten Rønholt, et al.
Published: (2017-11-01) -
Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study
by: Andrea Montes-Torres, et al.
Published: (2019-07-01) -
Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis
by: Cristina Membrive Jiménez, et al.
Published: (2021-04-01) -
Biologic therapy for psoriasis - still searching for the best target
by: Teresa Pinto-Almeida, et al.
Published: (2014-04-01)